Coherus BioSciences, Inc. (CHRS)
After hours:
| Previous close | 1.0400 |
| Open | 0.9900 |
| Bid | 1.0300 x 1800 |
| Ask | 1.0600 x 900 |
| Day's range | 0.9802 - 1.0800 |
| 52-week range | 0.9740 - 3.9800 |
| Volume | |
| Avg. volume | 2,155,089 |
| Market cap | 119.817M |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3800 |
| Earnings date | 04 Nov 2024 - 08 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 9.50 |
Insider MonkeyCoherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other Worst 52-Week Low Stocks. The U.S. Federal Reserve conducting a 50 basis point interest rate cut was the […]
- Insider Monkey
Short Interest Surges to 21.83% as Coherus BioSciences, Inc. (CHRS) Faces Revenue Challenges
We recently published a list of 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other worst 52-week low stocks to buy now according to short sellers. The U.S. Federal Reserve conducting a […]
Simply Wall St.Institutional owners may take dramatic actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent 12% drop adds to one-year losses
Key Insights Institutions' substantial holdings in Coherus BioSciences implies that they have significant influence...
